Skandinaviska Enskilda Banken (SEB)’s SpringWorks Therapeutics SWTX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$470K	–	883
2025 Q2	$470K	Buy	+10,000	New	+$445K	﹤0.01%	709

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s SWTX Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 10,000 shares — an estimated $470K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $470K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 10,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $470K.
Skandinaviska Enskilda Banken (SEB) first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s SpringWorks Therapeutics position peaked at $470K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.